| Factor Information | |
|---|---|
| Data ID | 2008 |
| Factor | NT-pro-BNP(female patients)(pg/ml) |
| Description | N/A |
| Biomarker | NA |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To ascertain if hyperuricaemia is associated with traditional cardiovascular risk factors such as dyslipidaemia. |
| p Value | 0.001 |
| Conclusion | Female congenital heart disease patients with higher serum uric acid concentrations (>5.7 mg/dl) were more obese, and with higher C-reactive protein and N-terminal-pro-B-type natriuretic peptide levels than those female congenital heart disease patients with lower serum uric acid concentrations (≤5.7 mg/dl). |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 575 |
| CHD Type | isolated CHD |
| CHD Subtype | VSD/TOF/ASD/CoA/PS/AVSD/TGA/AS/BAV/DORV/UVH/EA/PA/Ductus/TA/PTA/SAM/MVP/PVA/other |
| Reference | |
|---|---|
| PMID | 24702708 |
| Year | 2015 |
| Title | Hyperuricaemia in congenital heart disease patients |
| Sample | ||
|---|---|---|
| Population | adults | |
| Source | blood | |
| Region | Canaria, Spain | |
| Method | spectro-photometry, immunoassay | |
| Race | European | |
| Disease History | hypoxaemia | |
| Treatment History | N/A | |
| Group | serum uric acid≤5.7 mg/dl(Treatment) | serum uric acid>5.7 mg/dl(Control) |
| Number | 109 | 30 |
| Age | 28.4±13.3 years | 38.8±16.4 years |
| Gender (Male: Female) | 0:109 | 0:30 |
| Marker Level | 96.2(0.1;1157.8) pg/dl | 262.6(21.9;7824.1) pg/dl |
